Find a Trial

Trial Summary


Protocol No.CTO-JAB-3312-1003
StatusOPEN TO ACCRUAL
Principal InvestigatorTurk, Anita
ScopeNational
PhasePhase I/II
Age GroupAdult
TitleA Phase 1/2a, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-3312 in Combination with Pembrolizumab or Binimetinib in Adult Patients with Advanced Solid Tumors
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu